Drug Side Effects

Aminoglycoside Antibacterial [EPC]

34959 reported adverse events

Drugs of this class: TOBRAMYCIN TOBRAMYCIN AND DEXAMETHASONE TOBRAMYCIN INHALATION SOLUTION AMIKACIN LOTEPREDNOL ETABONATE AND TOBRAMYCIN TOBRAMYCIN / DEXAMETHASONE TOBRAMYCIN INHALATION TOBRAMYCIN OPHTHALMIC SOLUTION

These side effects are most commonly reported by patients taking drugs of the Aminoglycoside Antibacterial [EPC] class:

# Side effect Count
0 OFF LABEL USE 2862
1 DYSPNOEA 2310
2 DEATH 2252
3 COUGH 2198
4 DRUG INEFFECTIVE 1821
5 PNEUMONIA 1748
6 HOSPITALISATION 1581
7 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 1537
8 CONDITION AGGRAVATED 1234
9 CYSTIC FIBROSIS 1186
See all common reactions for Aminoglycoside Antibacterial [EPC]

Drugs of the Aminoglycoside Antibacterial [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 1537 0.3125
1 CYSTIC FIBROSIS LUNG 32 0.3019
2 CYSTIC FIBROSIS 1186 0.2477
3 CHOROIDITIS 72 0.2384
4 MYCOBACTERIUM ABSCESSUS INFECTION 109 0.2271
5 INFECTIVE EXACERBATION OF BRONCHIECTASIS 38 0.1919
6 CYSTIC FIBROSIS RESPIRATORY INFECTION SUPPRESSION 145 0.1792
7 SPUTUM INCREASED 194 0.1239
8 OTOTOXICITY 175 0.1179
9 PULMONARY FUNCTION TEST DECREASED 439 0.1164
See all enriched reactions for Aminoglycoside Antibacterial [EPC]